US EditionHIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers Health, Inc. Investors - Lead Plaintiff Deadline August 25, 2025
PHILADELPHIA COUNTY, PENNSYLVANIA, JUL 10 – The lawsuit alleges Hims & Hers misled investors about GLP-1 product legitimacy and concealed risks, including termination of a key Novo Nordisk partnership, causing share prices to drop over 34%.
- Levi & Korsinsky, LLP notified investors on July 11, 2025 of a class action lawsuit against Hims & Hers Health, Inc. alleging securities fraud.
- The lawsuit followed Novo Nordisk's June 23, 2025 termination of its partnership, amid allegations that Hims & Hers sold unapproved versions of semaglutide.
- The suit claims Hims & Hers made false or misleading statements about its GLP-1 offerings and risks during the class period from April 29 to June 23, 2025.
- Hims & Hers shares dropped over 34% in intraday trading on June 23, 2025, reflecting investor concern over regulatory compliance and deceptive marketing practices.
- Investors have the opportunity to apply for lead plaintiff status through August 25, 2025, and may pursue compensation without any upfront expenses by partnering with well-established firms such as Levi & Korsinsky or Berger Montague.
Insights by Ground AI
Does this summary seem wrong?
47 Articles
47 Articles
All
Left
4
Center
22
Right
4
Hims & Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights
NEW YORK, July 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.
The Courier-Tribune+39 Reposted by 39 other sources
CLASS ACTION REMINDER: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025
PHILADELPHIA, July 10, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).
Coverage Details
Total News Sources47
Leaning Left4Leaning Right4Center22Last UpdatedBias Distribution73% Center
Bias Distribution
- 73% of the sources are Center
73% Center
13%
C 73%
13%
Factuality
To view factuality data please Upgrade to Premium
